A 5-year Longitudinal Observational Study of the Natural History and Management of Patients With HCC

a study on Hepatocellular Cancer Liver Cancer

Summary

Eligibility
for people ages 18 years and up (full criteria)
Location
at Sacramento 5389489, California 5332921 and other locations
Dates
study started
study ends around

Description

Summary

TARGET-HCC is a longitudinal, observational study of patients being managed for HCC in usual clinical practice. TARGET-HCC will create a research registry of participants with HCC within academic and community real-world practices in order to assess the safety and effectiveness of the entire spectrum of current and future therapies across diverse populations.

Official Title

A Longitudinal Observational Study of the Natural History and Management of Patients With Hepatocellular Carcinoma

Keywords

Hepatocellular Cancer, Liver Neoplasms

Eligibility

You can join if…

Open to people ages 18 years and up

  1. Male or female patients, age ≥18 years
  2. Patients with a histological/cytological or radiological diagnosis of HCC (mixed HCC cholangiocarcinoma may be included; patients who are candidates for surgical and non-surgical treatment, as well as those being followed without specific HCC therapy may be included)

You CAN'T join if...

  1. Inability to provide written informed consent

Locations

  • University of California-Davis terminated
    Sacramento 5389489 California 5332921 95817 United States
  • University of California terminated
    San Francisco 5391959 California 5332921 94158 United States
  • Universitätsklinikum Düsseldorf accepting new patients
    Düsseldorf 2934246 Germany
  • Universitätsklinikum Frankfurt terminated
    Frankfurt 2925536 Germany
  • Medizinische Hochschule Hannover terminated
    Hanover 2910831 Germany
  • Universitätsklinikum Leipzig terminated
    Leipzig 2879139 Germany
  • Universitätsklinikum Magdeburg terminated
    Magdeburg 2874545 Germany
  • Universitätsmedizin Mainz terminated
    Mainz 2874225 Germany

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
Target PharmaSolutions, Inc.
Links
Sign up for this study
ID
NCT02954094
Study Type
Observational [Patient Registry]
Participants
Expecting 10000 study participants
Last Updated
Contact us about this trial